Abstract
We studied the effect of isoquinoline carboxamide (PK11195) applied alone or in combination with melatonin on the differentiation of N1E-115 mouse neuroblastoma cells (clone C-1300). PK11195 is a synthetic ligand of the mitochondrial translocator protein (TSPO), which is one of the mitochondrial proteins that are responsible for the opening of the mitochondrial pore (mPTP); expression of this protein is enhanced in different types of cancer cells. PK11195 is considered as a potential anticancer drug. It has been shown that PK11195 at a nontoxic/subtoxic concentration induces the differentiation of the N1Е-115 mouse neuroblastoma cells and suppresses cell proliferation; the magnitude of this effect coincides with the effect induced by melatonin at a nontoxic concentration. The combination of PK11195 with melatonin did not intensify its effect as a differentiation inducer. Based on the results of Western blot analysis, it has been hypothesized that the differentiation of N1Е-115 neuroblastoma cells is associated with the expression of mitochondrial 2’,3’-cyclonucleotide-3’-phosphodiesterase but not with the expression of the mitochondrial translocator protein TSPO.
Similar content being viewed by others
References
Bizzarri, M., Proietti, S., Cucina, A., and Reiter, R.J., Expert Opin. Ther. Targets, 2013, vol. 17, pp. 1483–1496.
Carlberg, C., Ann. NY Acad. Sci., 2000, vol. 917, pp. 387–396.
Stehle, J.H., Saade, A., Rawashdeh, O., Ackermann, K., Jilg, A., Sebesteny, T., and Maronde, E.., J. Pineal. Res., 2011, vol. 51, pp. 17–43.
Hardeland, R., Pandi-Perumal, S.R., and Cardinali, D.P., Int. J. Biochem. Cell Biol., 2006, vol. 38, pp. 313–316.
Shiu, S.Y.., J. Pineal. Res., 2007, vol. 43, pp. 1–9.
Gogvadze, V., Orrenius, S., and Zhivotovsky, B., Trends Cell Biol., 2008, vol. 18, pp. 165–173.
Kroemer, G., Galluzzi, L., and Brenner, C., Physiol. Rev., 2007, vol. 87, pp. 99–163.
McEnery, M.W., Snowman, A.M., Trifiletti, R.R., and Snyder, S.H., Proc. Natl. Acad. Sci. USA, 1992, vol. 89, pp. 3170–3174.
Austin, C.J., Kahlert, J., Kassiou, M., and Rendina, L.M., Int. J. Biochem. Cell Biol., 2013, vol. 45, pp. 1212–1216.
Gavish, M., Bachman, I., Shoukrun, R., Katz, Y., Veenman, L., Weisinger, G., and Weizman, A., Pharmacol. Rev., 1999, vol. 51, pp. 629–650.
Galiegue, S., Tinel, N., and Casellas, P., Curr. Med. Chem., 2003, vol. 10, pp. 1563–1572.
Katz, Y., Eitan, A., Gavish, M., Oncology, 1990, vol. 47, pp. 139–142.
Cornu, P., Benavides, J., Scatton, B., Hauw, J.J., and Philippon, J., Acta Neurochir. (Wien), 1992, vol. 119, pp. 146–152.
Hardwick, M., Fertikh, D., Culty, M., Li, H., Vidic, B., and Papadopoulos, V., Cancer Res., 1999, vol. 59, pp. 831–842.
Katz, Y., Ben-Baruch, G., Kloog, Y., Menczer, J., and Gavish, M. Clin. Sci. (Lond.), 1990, vol. 78, pp. 155–158.
Batra, S. and Iosif, C.S., Int. J. Oncol., 1998, vol. 12, pp. 1295–1298.
Venturini, I., Alho, H., Podkletnova, I., Corsi, L., Rybnikova, E., Pellicci, R., Baraldi, M., Pelto-Huikko, M., Helen, P., and Zeneroli, M.L., Life Sci., 1999, vol. 65, pp. 2223–2231.
Wu, X. and Gallo, K.A., PLoS One, 2013, vol. 8, p. e71258.
Beinlich, A., Strohmeier, R., Kaufmann, M., and Kuhl, H., Biochem. Pharmacol., 2000, vol. 60, pp. 397–402.
Landau, M., Weizman, A., Zoref-Shani, E., Beery, E., Wasseman, L., Landau, O., Gavish, M., Brenner, S., and Nordenberg, J., Biochem. Pharmacol., 1998, vol. 56, pp. 1029–1034.
Ikezaki, K., and Black, K.L., Cancer Lett., 1990, vol. 49, pp. 115–120.
Azarashvili, T., Krestinina, O., Galvita, A., Grachev, D., Baburina, Y., Stricker, R., Evtodienko, Y., and Reiser, G., Am. J. Physiol. Cell Physiol., 2009, vol. 296, pp. C1428–C1439.
Hinman, J.D., Chen, C.D., Oh, S.Y., Hollander, W., and Abraham, C.R., Glia, 2008, vol. 56, pp. 118–133.
McFerran, B. and Burgoyne, R., J. Cell Sci., 1997, vol. 110, no. 23, pp. 2979–2985.
Muller, H.W. and Seifert, W., Cell Mol. Neurobiol., 1982, vol. 2, pp. 227–239.
Kreutzberg, G.W., Trends Neurosci., 1996, vol. 19, pp. 312–318.
Dheen, S.T., Kaur, C., and Ling, E.A., Curr. Med. Chem., 2007, vol. 14, pp. 1189–1197.
Minagar, A., Shapshak, P., Fujimura, R., Ownby, R., Heyes, M., and Eisdorfer, C. J. Neurol. Sci., 2002, vol. 202, pp. 13–23.
Yang, L., Kan, E.M., Lu, J., Wu, C., and Ling, E.A., J. Neuroinflammation, 2014, vol. 11, p.148.
Aslanidi, K.B. and Myakisheva, S.N., Biol. Membrany, 2011, vol. 28, pp. 181–190.
Laemmli, U.K., Nature, 1970, vol. 227, pp. 680–685.
Pizarro, J.G., Yeste-Velasco, M., Esparza, J.L., Verdaguer, E., Pallas, M., Camins, A., and Folch, J., J. Pineal Res., 2008, vol. 45, pp. 8–16.
Myakisheva, S.N. and Krestinina, O.V., Modern Problems of Science and Education, Biologicheskiye Nauki, 2014, vol. 6, p.8.
Walter, R.B., Pirga, J.L., Cronk, M.R., Mayer, S., Appelbaum, F.R., and Banker, D.E., Blood, 2005, vol. 106, pp. 3584–3593.
Plescia, J., Salz, W., Xia, F., Pennati, M., Zaffaroni, N., Daidone, M.G., Meli, M., Dohi, T., Fortugno, P., Nefedova, Y., Gabrilovich, D.I., Colombo, G., and Altieri, D.C., Cancer Cell, 2005, vol. 7, pp. 457–468.
Batarseh, A. and Papadopoulos, V., Mol. Cell Endocrinol., 2010, vol. 327, pp. 1–12.
Author information
Authors and Affiliations
Corresponding author
Additional information
Original Russian Text © O.V. Krestinina, S.N. Myakisheva, Yu.L. Baburina, R.S. Fadeev, T.S. Azarashvili, V.S. Akatov, 2017, published in Neirokhimiya, 2017, Vol. 34, No. 1, pp. 41–48.
Rights and permissions
About this article
Cite this article
Krestinina, O.V., Myakisheva, S.N., Baburina, Y.L. et al. The effects of isoquinoline carboxamide and melatonin on the differentiation of N1Е-115 mouse neuroblastoma cells (clone C-1300) and on the expression of the TSPO translocation protein and 2’,3’-cyclonucleotide-3’-phosphodiesterase in these cells. Neurochem. J. 11, 31–37 (2017). https://doi.org/10.1134/S1819712417010044
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S1819712417010044